G
Gallant Pet
Stem Cell Banking for Dogs | Gallant
About Gallant Pet
Gallant is a pioneering company in the field of stem cell storage and regenerative therapy, specifically designed for dogs. The company offers a unique service that allows pet owners to bank their dog's stem cells during routine procedures like spaying or neutering. These stem cells can later be used for regenerative treatments to address various health issues such as arthritis, joint pain, and limited mobility, which are common in aging dogs. Gallant primarily serves pet owners who are proactive about their pets' long-term health and well-being. Operating in the pet healthcare market, Gallant employs a direct-to-consumer business model, making money through the sale of stem cell banking plans and subsequent regenerative treatments. The company leverages scientific advancements to provide a service that not only enhances the quality of life for pets but also offers peace of mind for their owners. By partnering with veterinarians, Gallant ensures a seamless process for stem cell collection and storage, making it convenient for pet owners to invest in their pets' future health.
Source: Dealroom company dataLatest news
Press, funding announcements and product moves mentioning Gallant Pet.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Jun 2025 | $18M | $72M | Digitalis Ventures · Bold Capital Partners · NovaQuest Capital Management · Hill Creek Partners | ↗ |
| SEED✓Equity / VC | Dec 2022 | — | — | Unpopular Ventures | — |
Growth signals
Latest recorded traffic for Gallant Pet is 23K monthly website visits, up 21.1% over the last three months. Gallant Pet's team grew 8.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
2 Future Holding
Series A11 investors entered at this stage
Maveron
Alpha Edison
Unpopular Ventures
Slow Ventures
Science
Expansion Venture Capital
Bold Capital Partners
Bling Capital
Digitalis Ventures
NovaQuest Capital Management- HPHill Creek Partners
Other known investors5 additional known investors
Alumni Ventures
Baroda Ventures
Daniel Curran
Justin Mateen
Western Technology Investment
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Gallant Pet on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Gallant Pet’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.